COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

Role of Anticoagulants and Antiplatelet Agents for Patients With COV…

CHEST 2022 Coverage

V. Balasubramanian

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

RheumNow News Highlights: 11 Agents That Cause Arthritis, Lupus - Te…

RheumNow

J. Cush

Clinical Approach to Diagnosis and Treatment of Cytokine Storm in Rh…

Cleveland Clinic Rheumatology

R. Q. Cron

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

Update on the New ANA Classification System

Keck School of Medicine of USC

E. Taylor-Albert

Points to Consider When Managing Inflammatory Arthritis with Cancer

RheumNow

J. Cush

Integrative Health Approaches for Optimum Immune Health

Cleveland Clinic Rheumatology

C. Wang

Management of Simultaneous Venous and Arterial Thromboembolic Disease

Scripps Health

J. May

Clinical Case Review: Cutaneous T Cell Lymphoma in the Patch Test Cl…

2024 Clinical Case Studies

J. Murase

Experts Discuss Key Updates in CLL

ASH 2022 Conference Coverage

S. O'Brien, C. Coombs

Diagnosis and Goals of Therapy in PV

Northwestern Medicine Oncology and Hematology

B. Stein

Current Review of Benign Hematology and Coagulopathy

Indy Hematology Review

C. Kessler

Learnings From the ELEVATE-TN Phase 3 Trial: Acalabrutinib+/-Obinutu…

Alan Skarbnik

Venous Thromboembolism Prophylaxis in Newly Diagnosed MM

Vanderbilt University Medical Center (VUMC)

M. Baljevic

2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Prevent…

Robert McBane

Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…

Jerry Spivak

Fred Hutchinson Cancer Center Update in Thromboembolism

Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

D. Garcia

​​ACR Convergence 2023 Highlights: People with RA and Long COVID Had…

RheumNow

R. Conway